by Press Release on (#5FNN4)
Results from a large clinical trial in the United States and South America indicate that AstraZeneca’s COVID-19 vaccine, AZD1222, is well-tolerated and protects against symptomatic COVID-19 disease, including severe disease or hospitalization. The independent Data and Safety Monitoring Board (DSMB) overseeing the trial identified no safety concerns related to the vaccine. The United Kingdom-based global […]The post AstraZeneca vaccine prevents COVID-19 according to results from a large clinical trial appeared first on Outbreak News Today.